Please assess the completion status of the following clinical trial:

Trial Title: Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females aged 18-65 years.~2. Patients will be initiating antibiotic therapy.~3. The antibiotic therapy consists of one of the following: broad spectrum penicillins, cephalosporins, doxycycline, clarithromycin, ciprofloxacin or isoxazolyl penicillin.~4. The antibiotic therapy is expected to be 3 to 14 days in duration.~5. Obtained his/her informed consent after verbal and written information.~6. Have a high probability for compliance with and completion of the study.~7. Patients having a telephone available.~8. Body Mass Index between 19 and 30.~Exclusion Criteria:~1. Participation in a clinical trial with an investigational product or drug within the 60 days prior to screening.~2. Likeliness to be noncompliant with the protocol, or to be unsuitable to the study by the investigator for any reason.~3. Pregnant or breastfeeding women; women planning to become pregnant during the study months.~4. Presence of active diarrhea (3 or more loose or watery stools per 24 hour period).~5. Daily consumption of probiotics, fermented milk and/or yogurt with probiotics.~6. Known to have a previous reaction, including anaphylaxis, to any substance in composition of the study product (i.e. on-medicinal ingredients: Cellulose, hypromellose, magnesium stearate (vegetable source), ascorbic acid, Colloidal silicon dioxide).~7. Presence of an active, non-controlled intestinal disease such as Crohn's Disease or ulcerative colitis.~8. Regular use of proton pump inhibitors.~9. Bowel surgery, artificial heart valve, history of rheumatic heart disease or infective endocarditis.~10. A previous documented C. difficile infection \< 3 months prior to study initiation.~11. Immunosuppressive therapy or any health condition causing immunosuppression (including haematological malignancies, AIDS).~12. Ongoing or recent use of antibiotic therapy in the 3 months prior to the study product first administration.~13. Planned administration of antibiotics other than broad spectrum penicillins, cephalosporins, doxycycline, ciprofloxacin or isoxazolyl penicillin for the treatment of an infection.~14. History of drug or alcohol abuse.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Probiotic (Type: ACTIVE_COMPARATOR): Probiotic consumption during and after course of antibiotic
- Placebo (Type: PLACEBO_COMPARATOR): Placebo consumed during and after course of antibiotic

Based on this trial design, predict the completion outcome and termination type (if applicable).